Showing results (111-120 of 270) with videos related to

Sort By:
Pageof 27
Cities & Health|April 6, 2026
Development intensity and incident stroke risk: a longitudinal study of the REGARDS cohortCathy L Antonakos, Ian-Marshall Lang, Stephanie Miller, et al.
Neurology|February 25, 2011
Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomesD Dowlatshahi, A M Demchuk, M L Flaherty, et al.
American Journal of Clinical Oncology|August 1, 1992
Effect of calcium replacement on the hemodynamic changes associated with high dose interleukin-2 therapyB G Redman, L Flaherty, S Martino, et al.
Neurosurgery|December 6, 2008
Surgical management and case-fatality rates of intracerebral hemorrhage in 1988 and 2005Opeolu Adeoye, Daniel Woo, Mary Haverbusch, et al.
Investigational New Drugs|August 1, 1992
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I studyE A Poplin, T Corbett, L Flaherty, et al.
Cancer Research|July 16, 2021
The Role of Psychologic Stress in Cancer Initiation: Clinical Relevance and Potential Molecular MechanismsMarta Falcinelli, Premal H Thaker, Susan K Lutgendorf, et al.
RSC Chemical Biology|June 3, 2022
A prodrug strategy for the in vivo imaging of aldehyde dehydrogenase activityRaul Pereira, Renée L Flaherty, Richard S Edwards, et al.
Clinical Genitourinary Cancer|February 26, 2014
Outcomes of patients with metastatic renal cell carcinoma and end-stage renal disease receiving dialysis and targeted therapies: a single institution experienceAditya V Shetty, Marc R Matrana, Bradley J Atkinson, et al.
Tissue Antigens|September 1, 1984
Utilization of murine peripheral blood lymphocytes for H-2 typingA L Watson, R J Mahoney, S A D'Amico, et al.
The Journal of Experimental Medicine|March 1, 1982
Antigen-specific soluble helper activity for murine major histocompatibility complex-encoded molecules. I. Kinetics of factor production after skin transplantation and genetic mapping of the H-2 region specificityJ M Plate, C A McDaniel, L Flaherty, et al.
Pageof 27